Table 2.
Characteristics of studies included – head and neck surgery.
| Study | Type of Study | Participants | Surgical technique | TXA Administration | Timing of TXA dose | Control | Primary Outcome | Main result |
|---|---|---|---|---|---|---|---|---|
| Das, 2015 | Randomized controlled trial | T: 40 C: 40 |
Unilateral H&N cancer surgeries (modified radical supraomohyoid, posterolateral neck dissection) | 20 mg/kg IV | 15 min before anaesthetic induction | IV saline | 1. Intraoperative blood loss (ml) 2. Red cell concentrate transfusion requirements (units) |
1. T: 52.34 ± 10.2, C 110.24 ± 13.4 (p = 0.0001) 2. T: 8, C: 42 p < 0.0001 |
| Kulkarni, 2016 | Randomized controlled trial | T: 108 C: 111 |
Composite resection of mandible + neck dissection + pedicled flaps (single or double) | 10 mg/kg IV | 20 min after anaesthetic induction | IV saline | Intraoperative blood loss (ml) | T: 750, C: 780 p = 0.22 |
| Chen, 2008 | Randomized controlled trial | T: 26 C: 29 |
Modified radical neck dissection, Hemithyroidectomy, Superficial parotidectomy | 10 mg/kg IV + 1 mg/kg/h IV | Preoperative + intraoperative | IV saline | 1. Drainage tube placement duration (h) 2. Drainage amount (ml) |
1. T: 2.69 ± 0.68, C: 3.07 ± 1.13 (p = 0.146) 2. T: 49.7 ± 32.6, C: 88.8 ± 89.9 (p = 0.041) |
C: control group, T: trial/intervention group, IV: intravenous.